Back

Local prevalence of ceftriaxone resistance informs optimal deploy-ment of new gonorrhea treatments

Oliveira Roster, K. I.; Rönn, M. M.; Gorenburg, E. R.; Partl, D. K.; Anderegg, N.; Abel zur Wiesch, P.; Au, C.; Kouyos, R. D.; Martinez, F. P.; Low, N.; Grad, Y. H.

2026-04-24 infectious diseases
10.64898/2026.04.23.26351610 medRxiv
Show abstract

Numerous factors may influence the optimal rollout of new gonococcal antibiotics. We compared eight rollout strategies using a gonorrhea transmission model and ranked strategies by the number of gonococcal infections and clinically useful antibiotic lifespan. Rankings were most sensitive to the starting ceftriaxone resistance prevalence and screening frequency.

Published in Open Forum Infectious Diseases (predicted rank #15) · training set

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.